再発性悪性神経膠腫(Recurrent Malignant Glioma):世界の治験レビュー(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Recurrent Malignant Glioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Recurrent Malignant Glioma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Recurrent Malignant Glioma 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Recurrent Malignant Glioma Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Merck & Co., Inc. 33
Clinical Trial Overview of Merck & Co., Inc. 33
INSYS Therapeutics, Inc. 34
Clinical Trial Overview of INSYS Therapeutics, Inc. 34
Eli Lilly and Company 35
Clinical Trial Overview of Eli Lilly and Company 35
Eisai Co., Ltd. 36
Clinical Trial Overview of Eisai Co., Ltd. 36
TransMolecular, Inc. 37
Clinical Trial Overview of TransMolecular, Inc. 37
Tactical Therapeutics, Inc 38
Clinical Trial Overview of Tactical Therapeutics, Inc 38
Shandong Lanjin Pharmaceuticals Co. Ltd 39
Clinical Trial Overview of Shandong Lanjin Pharmaceuticals Co. Ltd 39
Oncolytics Biotech Inc. 40
Clinical Trial Overview of Oncolytics Biotech Inc. 40
Amgen Inc. 41
Clinical Trial Overview of Amgen Inc. 41
Alkermes Plc 42
Clinical Trial Overview of Alkermes Plc 42
Clinical Trial Overview of Top Institutes / Government 43
National Cancer Institute 43
Clinical Trial Overview of National Cancer Institute 43
Duke University 45
Clinical Trial Overview of Duke University 45
Memorial Sloan Kettering Cancer Center 47
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 47
North American Brain Tumor Consortium 48
Clinical Trial Overview of North American Brain Tumor Consortium 48
University of Texas M. D. Anderson Cancer Center 49
Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center 49
Northwestern University 50
Clinical Trial Overview of Northwestern University 50
UCLA’s Jonsson Comprehensive Cancer Center 51
Clinical Trial Overview of UCLA’s Jonsson Comprehensive Cancer Center 51
City of Hope 52
Clinical Trial Overview of City of Hope 52
University of Colorado 53
Clinical Trial Overview of University of Colorado 53
Five Key Clinical Profiles 54
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 93


【レポート販売概要】

■ タイトル:再発性悪性神経膠腫(Recurrent Malignant Glioma):世界の治験レビュー(2015年上半期版)
■ 英文:Recurrent Malignant Glioma Global Clinical Trials Review, H1, 2015
■ 発行日:2015年2月18日
■ 調査会社:GlobalData
■ 商品コード:GDHC2563CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。